Lazard Capital Starts Nektar Therapeutics (NKTR) at Buy

January 15, 2013 6:44 AM EST Send to a Friend
Get Alerts NKTR Hot Sheet
Price: $12.99 +2.77%

Rating Summary:
    7 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 25 | New: 24
Trade NKTR Now!
Join SI Premium – FREE
Lazard Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $15.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $8.74 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Lazard

Add Your Comment